France· FR:65347835
MEMANTINE STRAGEN 10 mg/ml, solution buvable
A memantine product containing chlorhydrate de mémantine, registered in France by TAW PHARMA (IRLANDE). The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Memantine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Memantine · ATC N06DX01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of memantine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Memantine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- ES Spain$2.93
- CH Switzerland$2.47
- IT Italy$0.77
- US United States$0.22 (acquisition cost)
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE MÉMANTINE
- Manufacturer
- TAW PHARMA (IRLANDE)
- Country
- France (FR)
- ATC code
- N06DX01
- ATC class
- Memantine
- Defined daily dose
- 20 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300047151 flacon(s) en verre brun avec fermeture de sécurité enfant de 50 ml avec seringue(s) pour administration orale polypropylène polyéthylène haute densité (PEHD) avec adaptateur(s) pour flacon polyéthylène basse densité (PEBD)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
139 interactions on record for memantine.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Memantine · interactions on record
139 records
- 42 moderate
- 11 minor
- 80 info
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Memantine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainMEMANTINA ARISTO 10 MG/ML SOLUCION ORAL EFGAristo Pharma Iberia S.L.
- FinlandMemantin StadaSTADA Arzneimittel AG
- SwedenMemantin Medartuum 10 mg/ml Oral lösningMedartuum AB
- NetherlandsMemantine CF 10 mg/ml, drankCentrafarm B.V.
- IrelandMemantine Clonmel 10mg/ml Oral SolutionClonmel Healthcare Ltd
- BelgiumMemantine Sandoz 10 mg/mlSandoz
- ItalyMEMANTINA DOCDOC GENERICI S.R.L.
- CzechiaAXURAMerz Pharmaceuticals GmbH, Frankfurt am Main
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Alsemora, Memantin 1a Pharma
- Belgium · Alsemora, Memantine Eg
- Bulgaria · Memantine Grindeks, Имана
- Cyprus · Alzedem, Mantomed
- Czechia · Cognomem, Mantomed
- Germany · Alsemora, Memantin
- Denmark · Alsemora, Marbodin
- Estonia · Alsemora, Mantomed
- Spain · Alsemora, Mantinex
- Finland · Alsemora, Marbodin
- United Kingdom (Northern Ireland) · Memantine, Memantine Dawa
- Greece · Almerzac, Alsemora
- Croatia · Alsemora, Mantomed
- Hungary · Memantin Goodwill, Memantin Stada
- Ireland · Memantine Clonmel, Memantine Grindeks
- Iceland · Axura, Ebixa
- Italy · Demenco, Ezemantis
- Liechtenstein · Axura, Memantine Accord
- Lithuania · Alsemora, Maryzola
- Luxembourg · Memantine Eg
- Latvia · Alsemora, Mantomed
- Malta · Memantine Aurobindo, Memantine Clonmel
- Netherlands · Alsemora, Mantomed
- Norway · Alsemora, Axura
- Poland · Auromemo, Biomentin
- Portugal · Alsemora, Mantinex
- Romania · Alsemora, Memantina Atb
- Sweden · Alsemora, Marbodin
- Slovenia · Alsemora, Mantomed
- Slovakia · Alsemora, Mantomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b38f7d16-da49-45e7-a512-6f339e308b07 GET /v1/drugs/b38f7d16-da49-45e7-a512-6f339e308b07?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65347835",
"date_amm": "2015-12-21",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE MÉMANTINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about memantine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.